PPT-Treatment Resistance:

Client Issue or Counselor Challenge Debra E OrrBrown MSW CAP Corrections corporation of America CCA Why Talk about It After completing this workshop the participant will be able to. GUNA Summer Clinical Meeting . 28. th. June 2013. Antibiotic resistance in . Neisseria gonorrhoeae. Today’s prese. nta. tion. Overview of gonorrhoea. Disease. UK surveillance data. Antibiotic resistance. N. gonorrhoeae. . A Review. INTRODUCTION. Progressive antimicrobial resistance in . Neisseria gonorrhoeae . is an emerging public health threat. The Public Health Agency of Canada (the Agency) released updated recommendations in July 2013 for the diagnosis, treatment, follow-up and reporting of gonorrhea. Teresa . Lowery, MD, MPH, FAAFP, ABFM. Medical Health . Specialist, Region 2/3. Objectives. In this webinar, we . will. Define . “antibiotic resistance. ”; . and discuss . why . it has quickly become a growing public health threat.. Labaran. , CPIPP ABU Zaria . MALARIA: THE PROBLEM. Every year: worldwide. > 200 million clinical cases. > 2 million deaths from malaria mainly in Africa. DRUGS ARE FAILING . Pilot implementation of RTS,S/AS01 vaccine. Define drug resistance. Identify . factors that influence drug resistance. .. Identify . strategies for minimizing development of drug resistance.. Identify strategies for responding to detection of moderate to high levels of drug resistant HIV.. [NAME OF PRESENTER]. [TITLE OF PRESENTER]. STREAM Clinical Trial. Overview of the presentation. Outline. Burden of disease. TB treatments. Conclusions. Status of MDR TB in the world. Status of MDR/RR-TB . in the United States, 2013 TABLE OF CONTENTS Foreword .............................................................................................. . Executive Summary .............................. is an unsolved problem and has to be overcome to increase the prospect of many patients. As tumor angiogenesis was recognized to be a limiting factor in tumor progression, several treatment regimes King CH, Muchiri EM, Ouma JH. Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis. 2000;6(6):585-594. https://doi.org/10.3201/eid0606.000606. DRUG RESISTANT TB IN . CHILDREN. OUTLINE. Resistance patterns. Epidemiology. MDR TB in children. Diagnosis. Management. TB RESISTANCE PATTERNS. Mono-resistant TB. Resistant to any one drug.. Poly-resistant TB. per la gestione della tubercolosi. Marina Tadolini . Clinica di Malattie Infettive – Prof. Viale. Dipartimento di Scienze Mediche e Chirurgiche. Alma Mater . Studiorum. Università di Bologna. . in . Kirschner DE, Webb G. Resistance, Remission, and Qualitative Differences in HIV Chemotherapy. Emerg Infect Dis. 1997;3(3):273-283. https://doi.org/10.3201/eid0303.970303. Reaching Zero TB Deaths and Zero New TB Infections. Satellite Symposium, Kuala Lumpur, Malaysia. Dalene and Arne von Delft. 13 November 2012. Dalene von Delft. MB.ChB South Africa, 2006. Completed 2 years internship and 1 year community service, 2007-2009. The key components of treating infectious disease are:. •. Address any identifiable predisposing factor. , e.g. diabetes mellitus or known immune deficit (HIV, . neutropenia. ).. • . Antimicrobial therapy..